STM Journals Peer-reviewed research from Consortium e-Learning Network

International Journal of Fungi Review Article

The Mycobiome Frontier – Pre & Post 2020 Status: Integrating Fungal Bioactive Compounds, Probiotics, and Antimicrobial Peptides in Modern Therapeutics and Biotechnology.

  1. Mukesh Chander* P.G., Bioprocess Laboratory, Department of BioTechnology, Khalsa College, Amritsar
  2. Tejal Padda 1 Bioprocess Laboratory, P.G. Department of Biotechnology, Khalsa College ,Amritsar,

Abstract

The fungal kingdom represents an indispensable resource in modern therapeutics and biotechnology, offering a diverse array of bioactive compounds, probiotics, and antimicrobial peptides (AMPs). Functional fungal polysaccharides (FFPs), such as beta-glucans, chitin, and mannans, are centrally involved in modulating the human gut microbiota, providing novel therapeutic avenues for chronic conditions including diabetes, neurodegenerative disorders, and cancer. These compounds act as prebiotics, nourishing beneficial bacteria and enhancing metabolic parameters such as insulin sensitivity and glucose regulation. Concurrently, fungal probiotics, notably Saccharomyces boulardii and S. cerevisiae, are gaining recognition for their ability to reestablish eubiosis, enhance gut barrier functions, and modulate immune responses through the secretion of signaling molecules like short-chain fatty acids (SCFAs). Unlike bacterial counterparts, fungal probiotics are often inherently resistant to antibiotics, making them uniquely valuable for patients undergoing antimicrobial treatment. Furthermore, fungi produce potent antimicrobial peptides and specialized secondary metabolites that have historically defined the golden era of antibiotics and continue to serve as essential candidates for combating multidrug-resistant pathogens. In the sphere of biotechnology, the integration of fungal processes supports a circular bioeconomy through the high-yield production of industrial enzymes, organic acids, pigments, and sustainable mycelium-based materials. This synthesis of fungal applications, ranging from immunosuppressive drugs like cyclosporine to biofuel production, demonstrates the vast potential for personalizing medicine and promoting environmental sustainability. However, the transition to standard medical practice requires large-scale clinical trials to validate safety and efficacy. This review underscores the role of fungi as sustainable biological factories critical for next-generation therapeutic and industrial innovations.

Keywords

References (50)

  1. Zhang, Y., Wang, L., & Peng, L. (2025). The Role of Intestinal Fungi in the Pathogenesis and Treatment of Ulcerative Colitis. Microorganisms, 13(4), 794
  2. . https://doi.org/10.3390/ microorganisms13040794
  3. Divyashree S, Shruthi B, Vanitha PR, Sreenivasa MY. Probiotics and their postbiotics for the control of opportunistic fungal pathogens: A review. Biotechnology Reports. 2023;38:e00800. doi:10.1016/j.btre.2023.e00800
  4. Li, M., Yu, L., Zhao, J., Zhang, H., Chen, W., Zhai, Q., & Tian, F. (2021). Role of dietary edible mushrooms in the modulation of gut microbiota. Journal of Functional
  5. Foods, 83, 104538. https://doi.org/10.1016/j.jff.2021.104538
  6. Rousta N, Aslan M, Yesilcimen Akbas M, Ozcan F, Sar T, Taherzadeh MJ. Effects of fungal based bioactive compounds on human health: Review paper. Critical Reviews in Food Science and Nutrition. 2023;64(20):7004-7027. doi:10.1080/10408398.2023.2178379
  7. Chander, M. (2025). Fungal-derived Nutraceuticals & Bioactive Compounds with Physiotherapeutic and Health- promoting Properties: A Comprehensive Review.
  8. International Journal of Fungi, 2 (2), 1-9. https://journals.stmjournals .com/ijf/article =2025/view=228797. https://doi.org/10.37591/IJF.v02i02.228797
  9. Barcan, A. S., Barcan, R. A., & Vamanu, E. (2024). Therapeutic Potential of Fungal Polysaccharides in Gut Microbiota Regulation: Implications for Diabetes,
  10. Neurodegeneration and Oncology. Journal of Fungi, 10(6), 394. https://doi.org/10.3390/jof1006039417
  11. Hussain, A., Rabbani, N., Areeb, M., & Ali, S.A. (2025). Fungi as Probiotics: Properties and Applications. In book: Fungal Biotechnology Edition: 1. Chapter: 22. Publisher: CRC Press.
  12. Törős, G., El-Ramady, H., Prokisch, J., Velasco, F., Llanaj, X., H Nguyen, D. H., & Peles, F. (2023). Modulation of the Gut Microbiota with Prebiotics and Antimicrobial
  13. Agents from Pleurotus ostreatus Mushroom. Foods, 12(10), 2010. https://doi.org/10.3390 /foods 12102010
  14. Ventin-Holmberg R, Eberl A, Saqib S, Korpela K, Virtanen S, Sipponen T, et al. Bacterial and Fungal Profiles as Markers of Infliximab Drug Response in Inflammatory Bowel Disease. Journal of Crohn's and Colitis. 2020;15(6):1019-1031. doi:10.1093/ecco-jcc/jjaa252
  15. Chander, M. & Paul, M. (2025). Therapeutic & Diagnostic Applications of Biosurfactants of Microbial Origin. International Journal for Multidisciplinary Research, 7 (1), 1-25. https://doi.org.10.36948/ijfmr.2025. v07i04. 50288
  16. Kosgey JC, Jia L, Fang Y, Yang J, Gao L, Wang J, et al. Probiotics as antifungal agents: Experimental confirmation and future prospects. Journal of Microbiological Methods. 2019;162:28-37. doi:10.1016/j.mimet.2019.05.001
  17. Wang L, Li M, Liu C, Li X, Wang P, Chang J, et al. Effects of Fungal Probiotics on Rumen Fermentation and Microbiota in Angus Cattle. Animals. 2025;15(18):2746. doi:10.3390/ani15182746
  18. Haifer, C., Paramsothy, S., Kaakoush, N. O., Saikal, A., Ghaly, S., Yang, T., Luu, L. D. W., Borody, T. J., & Leong, R. W. (2022). Lyophilised oral faecal microbiota
  19. transplantation for ulcerative colitis (LOTUS): A randomised, double-blind, placebo- controlled trial. The Lancet Gastroenterology & Hepatology, 7(2), 141-151
  20. . https://doi.org/10.1016/S2468-1253(21)00400-3
  21. Kumar, R., Salwan, R., & Chander, M. (2023). The Synthesis of Medicinally Important Pharma Molecules from Carbohydrate Building Blocks. International Journal of Novel Research and Development, 8 (5): e138-148. https://ijnrd.org/viewpaperforall.php?paper= IJNRD2305414
  22. Wu, Y., Hu, S., Wu, C., Gu, F., & Yang, Y. (2022). Probiotics: Potential Novel 18 Therapeutics Against Fungal Infections. Frontiers in Cellular and Infection
  23. Microbiology, 11, 793419. https://doi.org/10.3389/fcimb.2021.793419
  24. Bulut, S.D., Döndaş, H.A., Celebioglu, H.U. et al. Recent Insights About Probiotics Related Pharmabiotics in Pharmacology: Prevention and Management of
  25. Diseases. Probiotics & Antimicro. Prot. 17, 2262–2292 (2025). https://doi.org/10.1007/s12602-025-10613-3
  26. Miguel, U.F. de., Sara, A., Enriqueta, G.G., & Cotter, P. D. (2020). Antifungal Peptides as Therapeutic Agents. Frontiers in Cellular and Infection
  27. Microbiology, 10, 518678. https://doi.org/10.3389/fcimb.2020.00105
  28. Abid R, Waseem H, Ali J, Ghazanfar S, Muhammad Ali G, Elasbali AM, et al. Probiotic Yeast Saccharomyces: Back to Nature to Improve Human Health. Journal of Fungi. 2022;8(5):444. doi:10.3390/jof8050444
  29. Corbu, V. M., Gheorghe-Barbu, I., Dumbravă, A. Ș., Vrâncianu, C. O., Șesan, T. E., Corbu, V. M., Gheorghe-Barbu, I., Dumbravă, A. Ș., Vrâncianu, C. O., & Șesan, T.E. (2023) . Current Insights in Fungal Importance: A Comprehensive Review. Microorganisms , 11(6). https://doi.org/10.3390 /microorganisms11061384
  30. Behar N, Sharma S, Parihar R, Dubey SK, Mehta S, Pandey V. Role of fungal metabolites in pharmaceuticals, human health, and agriculture. Fungal Secondary Metabolites. 2024:519-535. doi:10.1016/b978-0-323-95241-5.00005-8
  31. Sharma, E., Chander, M., & Kaur, K. (2024). Diagnosis Management & Treatment of Urinary Tract Infections: A Recent Perspective. International Journal of Current
  32. Research Academic Reviews, 12(8), 11-34. https://doi.org/10. 20546/ ijcrar. 2024.1208.002
  33. Ferrão, J., Bell, Chaquisse, E., Garrine, C., & Fernandes, T.H. (2020). The Synbiotic Role of Mushrooms: is Germanium a Bioactive Prebiotic Player? A Review
  34. Article. American Journal of Food and Nutrition, 7, 26-35.
  35. Zhang, F., Zuo, T., Yeoh, Y. K., Cheng, F. W., Liu, Q., Tang, W., Cheung, K. C., Yang, K., Cheung, C. P., Mo, C. C., Hui, M., Chan, F. K., Li, C., Chan, P. K., & Ng, S.
  36. Zhang F, Zuo T, Yeoh YK, Cheng FWT, Liu Q, Tang W, et al. Longitudinal dynamics of gut bacteriome, mycobiome and virome after fecal microbiota transplantation in graft-versus-host disease. Nature Communications. 2021;12(1). doi:10.1038/s41467-020-20240-x
  37. Chander, M. (2024). Rauwolfia serpentina: A Comprehensive Phytochemical Study of Its Bioactive Metabolites. Emerging Trends in Metabolites, 1(2), 14–40.
  38. https://journals.stmjournals.com/etm/ article=2024/view=170249
  39. Leonardi I, Gao IH, Lin WY, Allen M, Li XV, Fiers WD, et al. Mucosal fungi promote gut barrier function and social behavior via Type 17 immunity. Cell. 2022;185(5):831-846.e14. doi:10.1016/j.cell.2022.01.017
  40. Wang, X., Cui, Y., Sang, C., Wang, B., Yuan, Y., Liu, L., Yuan, Y., & Yue, T. (2022). Fungi with potential probiotic properties isolated from Fuzhuan brick
  41. tea. Food Science and Human Wellness, 11(3), 686- 696. https://doi.org/10.1016/j.fshw.2021.12.02
  42. Ghosh K, Harikrishnan R, Mukhopadhyay A, Ringø E. Fungi and Actinobacteria: Alternative Probiotics for Sustainable Aquaculture. Fishes. 2023;8(12):575. doi:10.3390/fishes8120575
  43. https://asm.org/press-releases/2023/october/fungi-used-in-food-production-could-lead-to- new-pr
  44. Chander, M., Kaur, J. 2024. Aquatic Ecosystems: A Review on Prospecting of Anticancer Molecules from Fungi & Other Microbes. International Journal of Fungi.
  45. 2024; 1 (2). https://journals.stmjournals.com/ijf/article=2024/view=172169
  46. Chen, S., Yi, M., Yi, X., Zhou, Y., Song, H., & Zeng, M. (2025). Unveiling the fungal frontier: Mycological insights into inflammatory bowel disease. Frontiers in
  47. Immunology, 16, 1551289. https://doi.org/10.3389/fimmu.2025.1551289
  48. Huang H, Wang Q, Yang Y, Zhong W, He F, Li J. The mycobiome as integral part of the gut microbiome: crucial role of symbiotic fungi in health and disease. Gut Microbes. 2024;16(1). doi:10.1080/19490976.2024.2440111
  49. Jaddaoui, I. E., Sehli, S., Idrissi, N. A., Bakri, Y., Belyamani, L., & Ghazal, H. (2025). The Gut Mycobiome for Precision Medicine. Journal of Fungi, 11 (4)
  50. . https://doi.org/10.3390/jof11040279